One of the world’s leading investment firms has broken its own record with the closing of its $6.3 billion Blackstone Life ...

Let’s explore the implications of this clinical achievement for Kodiak’s market position, the calculations behind its current ...

The post-pandemic bubble popped, but life sciences aren’t going anywhere. Blackstone announced Monday that it closed ...

By Siddhi Mahatole March 26 (Reuters) - Shares of Kodiak Sciences surged 68.6% to their highest in more than four years on ...

Wave Life Sciences (WVE) stock plunges as the company interim data from an early-stage trial for WVE-007, its RNA-based ...

The U.S. Patent and Trademark Office (USPTO) on Monday held the first of three planned Patent Trial and Appeal Board ...

Wave Life Sciences (NASDAQ:WVE) shares are trading near historic lows after two Wall Street firms cut their price targets ...

Galapagos (GLPG) backs Gilead’s Ouro Medicines deal, sharing $1.675B upfront and milestones, plus 20–23% royalties on gamgertamig—read more.

Shares of Kodiak Sciences shot higher after the company disclosed what it called positive results from a late-stage study of its treatment for diabetic retinopathy, a progressive disease that occurs ...

On March 26, 2026, traders mulled Wave's weak high-dose obesity results against the company's large market opportunity.

Family and consumer sciences professionals shape lives daily, support communities and quietly power some of the country’s most essential industries. For years, the value of that work has been clear to ...